Saikh, K.U.; Anam, K.; Sultana, H.; Ahmed, R.; Kumar, S.; Srinivasan, S.; Ahmed, H.
Targeting Myeloid Differentiation Primary Response Protein 88 (MyD88) and Galectin-3 to Develop Broad-Spectrum Host-Mediated Therapeutics against SARS-CoV-2. Int. J. Mol. Sci. 2024, 25, 8421.
https://doi.org/10.3390/ijms25158421
AMA Style
Saikh KU, Anam K, Sultana H, Ahmed R, Kumar S, Srinivasan S, Ahmed H.
Targeting Myeloid Differentiation Primary Response Protein 88 (MyD88) and Galectin-3 to Develop Broad-Spectrum Host-Mediated Therapeutics against SARS-CoV-2. International Journal of Molecular Sciences. 2024; 25(15):8421.
https://doi.org/10.3390/ijms25158421
Chicago/Turabian Style
Saikh, Kamal U., Khairul Anam, Halima Sultana, Rakin Ahmed, Simran Kumar, Sanjay Srinivasan, and Hafiz Ahmed.
2024. "Targeting Myeloid Differentiation Primary Response Protein 88 (MyD88) and Galectin-3 to Develop Broad-Spectrum Host-Mediated Therapeutics against SARS-CoV-2" International Journal of Molecular Sciences 25, no. 15: 8421.
https://doi.org/10.3390/ijms25158421
APA Style
Saikh, K. U., Anam, K., Sultana, H., Ahmed, R., Kumar, S., Srinivasan, S., & Ahmed, H.
(2024). Targeting Myeloid Differentiation Primary Response Protein 88 (MyD88) and Galectin-3 to Develop Broad-Spectrum Host-Mediated Therapeutics against SARS-CoV-2. International Journal of Molecular Sciences, 25(15), 8421.
https://doi.org/10.3390/ijms25158421
